v3.25.2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current assets      
Cash $ 316,578 $ 76,356 $ 472,509
Accounts receivable, net of allowance for doubtful accounts of $1,379,519 and $1,216,204, respectively 5,982,995 4,023,578 1,003,613
Original issuance discount 26,910  
Deferred financing costs 7,000  
Other assets 269 269 269
Total current assets 6,333,752 4,100,203 1,476,391
Furniture, fixtures, and equipment 9,321 6,498
Total assets 6,343,073 4,106,701 1,476,391
Liabilities and stockholders’ equity (deficit):      
Accounts payable and accrued liabilities 2,226,062 2,126,562 1,910,628
Deferred revenue 150,000
Notes payable 533,910 400,000
Accrued interest 20,518 13,250
Total current liabilities 2,780,490 2,539,812 2,128,837
Total liabilities 2,780,490 2,539,812 2,128,837
Commitments and Contingencies (Note 9)
Stockholders’ equity:      
Common stock, par value $0.0001, 300,000,000 shares authorized; 31,342,285 and 30,763,087 shares issued and outstanding, as of December 31, 2024, and December 31, 2023, respectively 3,134 3,134 3,077
Additional paid-in capital 30,033,430 30,033,430 24,060,884
Accumulated deficit (26,473,981) (28,469,675) (24,716,407)
Total stockholders’ equity (deficit) 3,562,583 1,566,889 (652,446)
Total liabilities and stockholders’ deficit: 6,343,073 4,106,701 1,476,391
Related Party [Member]      
Liabilities and stockholders’ equity (deficit):      
Accounts payable related party $ 68,209